![Charles Flynn](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Charles Flynn
Directeur/Membre du Conseil chez SynDevRx, Inc.
Profil
Charles Flynn is currently a Director at SynDevRx, Inc. He obtained his undergraduate degree from Yale University in 2000.
Postes actifs de Charles Flynn
Sociétés | Poste | Début |
---|---|---|
SynDevRx, Inc.
![]() SynDevRx, Inc. Miscellaneous Commercial ServicesCommercial Services SynDevRx, Inc. develops treatments for metabolic-related diseases. Its product includes SDX-7320, a polymer conjugate of fumagillol that releases a pharmacologically active small molecule fumagillol derivative in vivo. The company was founded by James M. Shanahan and Bradley J. Carver and is headquartered in Cambridge, MA. | Directeur/Membre du Conseil | - |
Formation de Charles Flynn
Yale University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 1 |
---|---|
SynDevRx, Inc.
![]() SynDevRx, Inc. Miscellaneous Commercial ServicesCommercial Services SynDevRx, Inc. develops treatments for metabolic-related diseases. Its product includes SDX-7320, a polymer conjugate of fumagillol that releases a pharmacologically active small molecule fumagillol derivative in vivo. The company was founded by James M. Shanahan and Bradley J. Carver and is headquartered in Cambridge, MA. | Commercial Services |